Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra-proactive TDM of Infliximab in IBD
NCT04775732Phase 4Completed
- Sponsor
- Imelda GI Clinical Research Center
- Start
- Jun 2018
- Primary completion
- Aug 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in Crohn's disease (CD), ulcerative colitis (UC), sponsored by Imelda GI Clinical Research Center. Started Jun 2018; status: completed.
02
Drugs
infliximab
03
Conditions
Crohn's disease (CD)ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04775732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04775732.